![]() |
|
|
Vol. 26, Issue 11, 1058-1062, November 1998
Naval Medical Research Institute Detachment-Toxicology (J.R.,
J.W.L., A.F.N.) and
Geo-Centers, Inc. (A.E.J., G.D.R.),
Wright-Patterson Air Force Base
The distribution, metabolism, and clearance of trimethylolpropane
phosphate (TMPP), a potent, bicyclophosphate,
-aminobutyric acid-ergic convulsant, were studied in male Fischer-344 rats. Intraperitoneal administration of TMPP was compared with oral gavage
with respect to rates of absorption, distribution, and clearance.
Distribution of TMPP to major body tissues was evaluated for the first
24 hr after administration or, in the case of regional brain
distribution, immediately after the first TMPP-induced clinical seizure. Samples purified from the urine, feces, and bile of rats exposed to TMPP, as well as from rat liver microsomes incubated with
TMPP in vitro, were analyzed for possible phase I and phase II metabolism, using HPLC. The disposition and clearance of TMPP in the
blood and major body tissues were measured. TMPP was found to be well
distributed to highly vascularized tissue compartments, with little
retention >24 hr after administration. TMPP was eliminated through the
urine and feces as the parent compound, with no evidence of phase I or
phase II metabolism. TMPP was rapidly cleared from the blood during the
first 30 min after exposure, with slower clearance of >87% of the
drug during the following 8-hr period and >99.5% clearance by 100 hr
after injection. Repeated daily exposure to TMPP for up to 5 successive
days resulted in no measurable accumulation in the brain or other major
tissue compartments. Possible mechanisms for TMPP-induced, short- and
long-term, neurobehavioral modulation are discussed.